Jack T. Pinney, Director at OptimizeRx Corp (OPRX), bought 4,000 shares at $0.80 ($3K) on 2016-12-13, disclosed to the SEC on 2016-12-21.
Open-market purchase of $3k OPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.